ADAR1 Capital Management, LLC
Transaction: 07/31/2026
BUY
Change
+3,300
Price
$4.98
Filing
08/03/2026
Type
BUY
NextCure, Inc.
NXTC • Biotechnology
$7.82
▼ -0.02 (-0.26%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$41.52M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.12Healthy liquidity · 4.14Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$7.82
Change-0.26%
Shares Out5.31M
Market Cap$41.52M
Enterprise Value$25.04M
52W Range1.59 - 15.74
Beta1.30
P/E-0.97
P/B3.42
P/FCF-0.82
EV/EBITDA-0.59
EV/FCF-0.50
Price$7.82
Change-0.26%
Shares Out5.31M
Market Cap$41.52M
Enterprise Value$25.04M
52W Range1.59 - 15.74
Beta1.30
P/E-0.97
P/B3.42
P/FCF-0.82
EV/EBITDA-0.59
EV/FCF-0.50
Earnings Yield-102.95%
FCF Yield-121.25%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.12
Current Ratio4.14
Quick Ratio4.14
Target$20.00
Target Upside155.75%
Target Median$20.00
Target Range20.00 - 20.00
Volume88.75K
Avg Volume94.35K
EPS Surprise-0.06
Investment DNA
How strong this company looks for long-term investors
47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
94/100
Why this score▼
Manageable debt level · 0.12Healthy liquidity · 4.14Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 13 analyst votes · 2026-09-04
88/100
Bullish
Bullish
11
Hold
1
Bearish
1
Price Target
2026-08-07
Low
$20.00
Mean
$20.00
Median
$20.00
High
$20.00
Insider Transactions
Recent executive and insider activity
ADAR1 Capital Management, LLC
Transaction: 07/30/2026
BUY
Change
+50,000
Price
$4.97
Filing
08/03/2026
Type
BUY
ADAR1 Capital Management, LLC
Transaction: 07/29/2026
BUY
Change
+1,810
Price
$5.00
Filing
07/29/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | BUY | +3,300 | $4.98 | 07/31/2026 | 08/03/2026 |
| ADAR1 Capital Management, LLC | BUY | +50,000 | $4.97 | 07/30/2026 | 08/03/2026 |
| ADAR1 Capital Management, LLC | BUY | +1,810 | $5.00 | 07/29/2026 | 07/29/2026 |
| ADAR1 Capital Management, LLC | BUY | +6,400 | $4.95 | 07/28/2026 | 07/29/2026 |
| ADAR1 Capital Management, LLC | OTHER | 0 | Not reported | 07/27/2026 | 07/29/2026 |
| Houston John G | BUY | +2,340 | $2.02 | 06/18/2026 | 06/22/2026 |
| KABAKOFF DAVID S | BUY | +3,510 | $2.02 | 06/18/2026 | 06/22/2026 |
| Webster Stephen W | BUY | +2,340 | $2.02 | 06/18/2026 | 06/22/2026 |
| Borgman Anne Elizabeth | BUY | +2,340 | $2.02 | 06/18/2026 | 06/22/2026 |
| Jones Elaine V | BUY | +2,340 | $2.02 | 06/18/2026 | 06/22/2026 |
| Feigal Ellen | BUY | +2,340 | $2.02 | 06/18/2026 | 06/22/2026 |
| Cobourn Steven P. | BUY | +14,670 | $10.85 | 01/30/2026 | 02/03/2026 |
| Richman Michael | BUY | +38,190 | $10.85 | 01/30/2026 | 02/03/2026 |
| Mayer Timothy | BUY | +14,670 | $10.85 | 01/30/2026 | 02/03/2026 |
| Kundu Sourav | BUY | +8,270 | $10.85 | 01/30/2026 | 02/03/2026 |
| Guha Udayan | BUY | +14,670 | $10.85 | 01/30/2026 | 02/03/2026 |
| Shaw Kevin G. | BUY | +8,270 | $10.85 | 01/30/2026 | 02/03/2026 |
| Simcere Zaiming, Inc. | OTHER | 0 | Not reported | 06/20/2025 | 08/19/2025 |
| Feigal Ellen | BUY | +18,700 | $0.47 | 06/20/2025 | 06/24/2025 |
| Webster Stephen W | BUY | +18,700 | $0.47 | 06/20/2025 | 06/24/2025 |